| Primary |
| Nasopharyngitis |
14.7% |
| Pyrexia |
11.8% |
| Nail Infection |
8.8% |
| Back Pain |
5.9% |
| Otitis Media |
5.9% |
| Otitis Media Acute |
5.9% |
| Tonsillitis |
5.9% |
| Upper Respiratory Tract Infection |
5.9% |
| Antibiotic Therapy |
2.9% |
| Anxiety Disorder |
2.9% |
| Arthralgia |
2.9% |
| Dyslipidaemia |
2.9% |
| Ear Infection |
2.9% |
| Infection |
2.9% |
| Pharyngitis |
2.9% |
| Pharyngolaryngeal Pain |
2.9% |
| Prophylaxis |
2.9% |
| Prostatitis |
2.9% |
| Respiratory Tract Infection |
2.9% |
| Sinusitis |
2.9% |
|
| Haematochezia |
12.5% |
| Vomiting |
12.5% |
| Urticaria |
9.4% |
| Loss Of Consciousness |
6.3% |
| Pyrexia |
6.3% |
| Rash |
6.3% |
| Tachycardia |
6.3% |
| Anaphylactic Reaction |
3.1% |
| Anaphylactic Shock |
3.1% |
| Death |
3.1% |
| Drug Ineffective |
3.1% |
| Erythema |
3.1% |
| Hypersensitivity |
3.1% |
| Nightmare |
3.1% |
| Rash Generalised |
3.1% |
| Sensory Disturbance |
3.1% |
| Septic Shock |
3.1% |
| Serum Sickness |
3.1% |
| Streptococcal Infection |
3.1% |
| Swelling Face |
3.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
35.0% |
| Abdominal Pain Upper |
7.5% |
| Ear Infection |
7.5% |
| Sinusitis |
7.5% |
| Tonsillitis |
5.0% |
| Antiemetic Supportive Care |
2.5% |
| Back Pain |
2.5% |
| Blood Cholesterol Increased |
2.5% |
| Blood Pressure |
2.5% |
| Crohn's Disease |
2.5% |
| Diabetes Mellitus |
2.5% |
| Infection |
2.5% |
| Nail Infection |
2.5% |
| Neuropathy Peripheral |
2.5% |
| Oedema |
2.5% |
| Pain |
2.5% |
| Pain In Extremity |
2.5% |
| Product Used For Unknown Indication |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Smoking Cessation Therapy |
2.5% |
|
| Drug Hypersensitivity |
66.2% |
| No Adverse Event |
5.6% |
| Rash |
4.2% |
| Urticaria |
4.2% |
| Thrombotic Thrombocytopenic Purpura |
2.8% |
| White Blood Cell Count Increased |
2.8% |
| Anaphylactic Shock |
1.4% |
| Hypersensitivity |
1.4% |
| Medication Error |
1.4% |
| Nausea |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Silent Myocardial Infarction |
1.4% |
| Sinusitis |
1.4% |
| Tooth Decalcification |
1.4% |
| Tooth Malformation |
1.4% |
| Vasculitis |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.9% |
| Drug Use For Unknown Indication |
10.5% |
| Rheumatoid Arthritis |
7.0% |
| Hypertension |
5.8% |
| Infection |
5.8% |
| Dyspnoea |
4.7% |
| Haemoptysis |
4.7% |
| Diabetes Mellitus |
4.1% |
| Acne |
3.5% |
| Arthritis |
3.5% |
| Bacterial Infection |
3.5% |
| Blood Cholesterol Decreased |
3.5% |
| Contraception |
3.5% |
| Crohn's Disease |
3.5% |
| Pain |
3.5% |
| Pneumonia |
3.5% |
| Premenstrual Syndrome |
3.5% |
| Vascular Injury |
3.5% |
| Constipation |
2.9% |
| Pollakiuria |
2.9% |
|
| Vomiting |
10.9% |
| Renal Failure |
8.7% |
| Epididymitis |
6.5% |
| Oedema Peripheral |
6.5% |
| Rash |
6.5% |
| Uterine Leiomyoma |
6.5% |
| Blood Glucose Increased |
4.3% |
| Cough |
4.3% |
| Hepatitis |
4.3% |
| Injury |
4.3% |
| Nausea |
4.3% |
| Nephritis Interstitial |
4.3% |
| Pulmonary Embolism |
4.3% |
| Therapeutic Agent Toxicity |
4.3% |
| Thrombosis |
4.3% |
| Thyroid Disorder |
4.3% |
| Upper Gastrointestinal Haemorrhage |
4.3% |
| Acute Myeloid Leukaemia |
2.2% |
| Anal Fistula |
2.2% |
| Blood Testosterone Decreased |
2.2% |
|
